Skip to main content

Notice for gilteritinib (as fumarate) (Astellas Pharma Australia Pty Ltd)

Active ingredients
gilteritinib (as fumarate)
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of acute myeloid leukemia.
Therapeutic area
Haematology

Help us improve the Therapeutic Goods Administration site